We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.

The KCNQ1-KCNE2 K⁺ channel is required for adequate thyroid I⁻ uptake.

TitleThe KCNQ1-KCNE2 K⁺ channel is required for adequate thyroid I⁻ uptake.
Publication TypeJournal Article
Year of Publication2012
AuthorsPurtell K, Paroder-Belenitsky M, Reyna-Neyra A, Nicola JP, Koba W, Fine E, Carrasco N, Abbott GW
JournalFASEB J
Date Published2012 Aug
KeywordsAnimals, Cercopithecus aethiops, COS Cells, Humans, Hypothyroidism, Iodides, KCNQ1 Potassium Channel, Mice, Positron-Emission Tomography, Potassium Channels, Voltage-Gated, Symporters, Thyroid Gland

The KCNQ1 α subunit and the KCNE2 β subunit form a potassium channel in thyroid epithelial cells. Genetic disruption of KCNQ1-KCNE2 causes hypothyroidism in mice, resulting in cardiac hypertrophy, dwarfism, alopecia, and prenatal mortality. Here, we investigated the mechanistic requirement for KCNQ1-KCNE2 in thyroid hormone biosynthesis, utilizing whole-animal dynamic positron emission tomography. The KCNQ1-specific antagonist (-)-[3R,4S]-chromanol 293B (C293B) significantly impaired thyroid cell I(-) uptake, which is mediated by the Na(+)/I(-) symporter (NIS), in vivo (dSUV/dt: vehicle, 0.028 ± 0.004 min(-1); 10 mg/kg C293B, 0.009 ± 0.006 min(-1)) and in vitro (EC(50): 99 ± 10 μM C293B). Na(+)-dependent nicotinate uptake by SMCT, however, was unaffected. Kcne2 deletion did not alter the balance of free vs. thyroglobulin-bound I(-) in the thyroid (distinguished using ClO(4)(-), a competitive inhibitor of NIS), indicating that KCNQ1-KCNE2 is not required for Duox/TPO-mediated I(-) organification. However, Kcne2 deletion doubled the rate of free I(-) efflux from the thyroid following ClO(4)(-) injection, a NIS-independent process. Thus, KCNQ1-KCNE2 is necessary for adequate thyroid cell I(-) uptake, the most likely explanation being that it is prerequisite for adequate NIS activity.

Alternate JournalFASEB J.
PubMed ID22549510
PubMed Central IDPMC3405278
Grant List5T32GM002788 / GM / NIGMS NIH HHS / United States
DK41544 / DK / NIDDK NIH HHS / United States
HL079275 / HL / NHLBI NIH HHS / United States
R01 HL079275 / HL / NHLBI NIH HHS / United States
T32 GM007288 / GM / NIGMS NIH HHS / United States
T32GM073546 / GM / NIGMS NIH HHS / United States